SGLT2 HYPE: A groundbreaking trial exploring dapagliflozin for better blood pressure control in 3,200 high-risk elderly patients. Advancing hypertension care!

ID: 1899780601911111680

linkhttps://www.sglt2-hype.eu/ calendar_today12-03-2025 11:13:34